Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021)

Ascendis Pharma A (ASND) has 3 years of Construction in Progress data on file, last reported at $2173.5 in Q4 2021.

• For the quarter ending Q4 2021, Construction in Progress fell 20.74% year-over-year to $2173.5; the trailing twelve-month figure through Dec 2021 stood at $2173.5 (down 20.74% YoY), and the FY2021 full-year result was $2173.5, down 20.74% from the prior year.
• Construction in Progress retreated to $2173.5 in Q4 2021, from $2742.3 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $3.0 million in Q4 2019 to a low of $2173.5 in Q4 2021.
• A 3-year average of $997837.5 and a median of $2742.3 in 2020 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress slumped 99.91% in 2020 and declined 20.74% in 2021, its largest moves.
• Tracing ASND's Construction in Progress over 3 years: stood at $3.0 million in 2019, then tumbled by 99.91% to $2742.3 in 2020, then retreated by 20.74% to $2173.5 in 2021.
• Business Quant data shows ASND's Construction in Progress at $2173.5 in Q4 2021, $2742.3 in Q4 2020, and $3.0 million in Q4 2019.